Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewei Allison Lin

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Annals of Family Medicine|May 16, 2019
Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United StatesLewei Allison Lin, Hannah K Knudsen
Substance Abuse|October 12, 2022
Defining and supporting high-quality telehealth for patients with opioid use disorder: The promise and potential pitfalls of telehealth expansionChristopher J Frank, Lewei Allison Lin
Health Affairs Scholar|May 17, 2024
Association of licensure and relationship requirement waivers with out-of-state tele-mental health care, 2019-2021Antonios M Koumpias, Owen Fleming, Lewei Allison Lin
Substance Abuse|July 12, 2019
Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysisHannah K Knudsen, Lewei Allison Lin, Michelle R Lofwall
The Psychiatric Quarterly|October 9, 2014
Comparing antipsychotic treatments for schizophrenia: a health state approachLewei Allison Lin, Robert Rosenheck, Catherine Sugar, et al.
JAMA Network Open|October 12, 2022
Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 PandemicMadeline C Frost, Lan Zhang, H Myra Kim, et al.
Journal of Addiction Medicine|June 4, 2024
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health AdministrationMadeline C Frost, Lara N Coughlin, Lan Zhang, et al.
The American Journal of Psychiatry|July 28, 2022
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use DisorderLewei Allison Lin, Lan Zhang, Hyungjin Myra Kim, et al.
Drug and Alcohol Dependence|September 28, 2023
Impact of COVID-19 on stimulant use disorder treatment: A national cohort study in the Veterans Health AdministrationLara N Coughlin, Madeline C Frost, Lan Zhang, et al.
Addictive Behaviors|January 29, 2019
Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialtiesLewei Allison Lin, Michelle R Lofwall, Sharon L Walsh, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Annals of Family Medicine|May 16, 2019
Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United StatesLewei Allison Lin, Hannah K Knudsen
Substance Abuse|October 12, 2022
Defining and supporting high-quality telehealth for patients with opioid use disorder: The promise and potential pitfalls of telehealth expansionChristopher J Frank, Lewei Allison Lin
Health Affairs Scholar|May 17, 2024
Association of licensure and relationship requirement waivers with out-of-state tele-mental health care, 2019-2021Antonios M Koumpias, Owen Fleming, Lewei Allison Lin
Substance Abuse|July 12, 2019
Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysisHannah K Knudsen, Lewei Allison Lin, Michelle R Lofwall
The Psychiatric Quarterly|October 9, 2014
Comparing antipsychotic treatments for schizophrenia: a health state approachLewei Allison Lin, Robert Rosenheck, Catherine Sugar, et al.
JAMA Network Open|October 12, 2022
Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 PandemicMadeline C Frost, Lan Zhang, H Myra Kim, et al.
Journal of Addiction Medicine|June 4, 2024
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health AdministrationMadeline C Frost, Lara N Coughlin, Lan Zhang, et al.
The American Journal of Psychiatry|July 28, 2022
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use DisorderLewei Allison Lin, Lan Zhang, Hyungjin Myra Kim, et al.
Drug and Alcohol Dependence|September 28, 2023
Impact of COVID-19 on stimulant use disorder treatment: A national cohort study in the Veterans Health AdministrationLara N Coughlin, Madeline C Frost, Lan Zhang, et al.
Addictive Behaviors|January 29, 2019
Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialtiesLewei Allison Lin, Michelle R Lofwall, Sharon L Walsh, et al.
Pageof 5